CGIX - Cancer Genetics under pressure after $10M capital raise

Cancer Genetics (CGIX) inks securities purchase agreements with certain institutional investors to raise ~$10M through issuance of an ~2.8M common shares and warrants to purchase common shares, at a combined price of $3.625/share and warrant in a private placement priced at-the-market. The five and one-half years warrants have an exercise price of $3.50/share. Net proceeds will be used for general corporate purposes, including working capital.Closing date is February 1.Shares down 17% premarket.

For further details see:

Cancer Genetics under pressure after $10M capital raise